SCHEMBL15763545

SCHEMBL15763545

Brc1c2ccccc2c(-c2cncc3ccccc23)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRKCZ Q05513 1/20 0.50
CYP11B2 P19099 14/20 0.43
CYP11B1 P15538 10/20 0.42
CYP3A4 P08684 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP17A1 P05093 3/20 0.41
KCNA5 P22460 1/20 0.38
KCNH2 Q12809 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
ADRA1A P35348 1/20 0.38
ERN1 O75460 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13978916 0.90 PRKCZ (0.58) PRKCZCYP11B2CYP11B1CYP3A4CYP1A2
SCHEMBL14461164 0.83 PRKCZ (0.51) PRKCZCYP11B2CYP11B1CYP3A4CYP1A2
SCHEMBL15763544 0.81 PRKCZ (0.46) PRKCZCYP11B2CYP11B1CYP3A4CYP1A2
SCHEMBL20873066 0.80 PRKCZ (0.64) PRKCZCYP11B2CYP11B1CYP3A4CYP1A2
SCHEMBL24662637 0.79 PRKCZ (0.56) PRKCZCYP11B2CYP11B1CYP3A4CYP1A2
SCHEMBL133949 0.78 PRKCZ (0.50) PRKCZCYP11B2CYP11B1CYP3A4CYP1A2
SCHEMBL29351773 0.76 DHFR (0.43) CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL1680196 0.76 DHFR (0.43) CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL24662630 0.76 CYP11B1 (0.58) PRKCZCYP11B2CYP11B1CYP3A4CYP1A2
SCHEMBL20128338 0.75 PRKCZ (0.47) PRKCZCYP11B2CYP11B1CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9818951-B2 Polycyclic compound and organic electronic device comprising the same LG CHEM, LTD. (KR) 2017-11-14 US disclosed
US-9818951-B2 Polycyclic compound and organic electronic device comprising the same LG CHEM, LTD. (KR) 2017-11-14 US disclosed
US-20160329500-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME LG CHEM LTD. (KR) 2016-11-10 US disclosed
US-20160329500-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME LG CHEM LTD. (KR) 2016-11-10 US disclosed
US-9484539-B2 Polycyclic compound and organic electronic device comprising the same LG CHEM, LTD. (KR) 2016-11-01 US disclosed
US-9484539-B2 Polycyclic compound and organic electronic device comprising the same LG CHEM, LTD. (KR) 2016-11-01 US disclosed
US-20140151670-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2014-06-05 US disclosed
US-20140151670-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2014-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160329500-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME PIEZO1, EED, ETV6 PRKCZ 4442/4885CYP11B2 2837/4885CYP11B1 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.